Introducing HIV Outcomes Italy

HIV Outcomes Italy consists of the following members:

  • Mario Cascio – European AIDS Treatment Group (EATG)
  • Professor Antonella d’Arminio Monforte – University of Milan
  • Marcello Tavio – Ospedali Riuniti Ancona
  • Lorenzo Badia – University of Bologna
  • Antonio Di Biagio – Italian Ministry of Health
  • Sergio Lo Caputo – Università degli studi di Foggia
  • Claudio Mastroianni – Sapienza University of Rome
  • Massimo Cernuschi – ASA ONLUS
  • Bruno Marchini – Anlaids
  • Anna Maria Cattelan – University of Padova
  • Giovanni Guaraldi – University of Modena and Reggio Emilia
  • Massimo Oldrini – Lila
  • Professor Cristina Mussini – European AIDS Clinical Society
  • Margherita Errico – NPS Italia
  • Sandro Mattioli – Plus APS
  • Andrea Antinori – Italian Ministry of Health

Activities & Milestones

HIV Outcomes Italy was launched in 2020 in partnership with The Bridge Foundation, with the aim of raising awareness among national policymakers, MPs and other relevant stakeholders on the existing challenges of living with HIV. The ultimate goal is to work towards the implementation of HIV Outcomes’ Europe recommendations and vision at national level.

September – November 2022

Analysis of the new institutional framework and mapping of political decision-makers after 25 September general elections in Italy.

Launch of the 2022 Italian Good Practices Report, with policy reccomendations to improve long-term care of people living with HIV.

June – July 2022

Creation and dissemination of an informative leaflet which includes a presentation of our vision and mission, as well as HIV Outcomes’ main policy recommendations.

Transmission and dissemination at a National level of the letter requesting the integration of the European Care Strategy.

March – May 2022

Advocacy at National level for the extension of the remit of the European Commission’s Steering Group on Health Promotion, Disease Prevention and Management of Non-Communicable Diseases to also include Communicable Diseases.

January – February 2022

Dissemination of the final reportProposals for an integrated approach to health in people living with HIV: HIV Outcomes Italy’ among Italian stakeholders.

November – December 2021

Presentation of the final reportProposals for an integrated approach to health in people living with HIV: HIV Outcomes Italy’ to Members of the Italian Parliament as well as Members of the European Parliament, and dissemination of the report at the Conference of Regions and Autonomous Provinces.

July – October 2021

Analysis of the input received from the Delphi questionnaire and draft of the final report in Italian. 

May – June 2021

Final results of the Delphi questionnaire were received, and a discussion was held among all relevant stakeholders to begin drafting the final report.

April 2021

A second round of Delphi questionnaire was shared with both community representatives and clinicians.

March 2021

Delphi questionnaire was shared with clinicians and community representatives with the aim to gather information on the current situation in Italy, exploring challenges and barriers to quality of life and identifying possible solutions to address them.

The questionnaire is based on the five recommendations on long-term health, well-being and chronic care for people living with HIV developed by HIV Outcomes Europe in 2017.

February 2021

A first meeting of a focus group gathering clinicians involved in HIV care was convened in February 2021 with the aim of identifying the existing gaps in the way healthcare systems currently address the quality of life of people living with HIV.

January 2021

A first focus group bringing together community-based organisations was organized with the aim of capturing the community perspective on the existing gaps in the way HIV care currently addresses the quality of life of people living with HIV.

December 2020

HIV Outcomes Italy kicked off activities at the end of 2020, with the setup of a group of community representatives and clinicians.

This initiative is enabled by sponsorship provided by Gilead Sciences and ViiV Healthcare.

Privacy Preference Center


Cookies that are necessary for the site to function properly.

wfvt_{hash}, gdpr, wordpress_{hash}, wordpress_logged_in_{hash}, wordpress_test_cookie, _cfduid